Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Nitro Games Oyj: Managers’ Transactions

Person subject to the notification requirementName:                                                        Jasperus S.A.Position:                                                    Closely associated person  Person discharging managerial responsibilities in issuer Name:                                                        Ehrnrooth, Jacob Position:                                                    Member of the Board Notification type:                                       Initial notificationIssuer Name:                                              Nitro Games Oyj

Nitro Games Oyj: Managers’ Transactions

Person subject to the notification requirementName:                                                        Immonen, JussiPosition:                                                    Chief Operating Officer Person discharging managerial responsibilities in issuer Name:                                                         Position:                                                     Notification type:                                       Initial notificationIssuer Name:                                              Nitro Games OyjLEI:

Nitro Games Oyj: Managers’ Transactions

Person subject to the notification requirementName:                                                        Savox S.A.Position:                                                    Closely associated person  Person discharging managerial responsibilities in issuer Name:                                                        Ehrnrooth, Jacob Position:                                                    Member of the Board Notification type:                                       Initial notificationIssuer Name:                                              Nitro Games OyjLEI:

heroal receives German Design Award 2020 for Excellent Product Design

Verl, November 2019. As a manufacturer of high-quality aluminium system solutions for building shells, heroal has received a German Design Award for 2020. The company was awarded a prize in the “Excellent Product Design” category for its heroal Les Couleurs[®] Le Corbusier front door.The German Design Award 2020 jury was won over by heroal's ability to combine contemporary design with a unique colour scheme in its heroal Les Couleurs[®] Le Corbusier front door. “Not only does the system facilitate individual colouring of all front door components, but also allows free combination of the

Indutrade acquires Intergate – a Swedish supplier of security solutions

Indutrade has on 22 November signed an agreement to acquire all of the shares in Intergate AB, with annual sales of approximately SEK 40 million. Intergate is a supplier of security products such as boom barriers, entry gates, bollards, and security access controlled gates. Since 1995, Intergate has been providing automated solutions for both personal safety and smooth access of vehicles, to companies, government authorities, sports facilities and airports in the Swedish market. Intergate offers customized installations of high quality products from European

CORRECTION: 2cureX publishes interim report for the third quarter of 2019

2cureX AB (“2cureX”) hereby publishes interim report for the third quarter of 2019. The interim report is available as an attached document as well as on the company’s website (www.2curex.com). Below follows a short summary of the report. The correction is due to the fact that the report was not attached to the previous release.CEO Ole Thastrup comments “We remain fully focused on the commercialization of IndiTreat with a planned launch of IndiTreat in 2020. Further, we push our multiple clinical studies to capitalize on a significantly increased interest for introducing 3D functional

Fresh report identifies environmental impacts of lifecycle of natural gas imported into Finland

Gasum commissioned international consulting company Pöyry to study the lifecycle environmental impacts of the natural gas supplied from Russia to Finland as well as a calculation of lifecycle air emissions. The environmental impacts studied included climate warming, soil and vegetation impacts, the use of natural resources as well as the impacts of waste management and wastewater treatment.Greenhouse gas emissions are the most significant environmental impact in the natural gas lifecycle, i.e. production, transmission and use, with use of natural gas accounting for 80% of the greenhouse gas

Arve Regland appointed new CFO of Heimstaden

Arve Regland, 47, will as of today take on the role as CFO of Heimstaden.  Arve has and will continue to have the same role in Heimstaden’ s majority owner Fredensborg AS and replaces acting CFO Magnus Nordholm who wants to focus fully on his role as CEO of Fredensborg AS and as a board member in Heimstaden. Arve joined Fredensborg as CFO in August 2019. He most recently came from the position as CEO of the Norwegian listed property company Entra ASA. Prior to that he worked for 10 years with real estate and finance at ABG Sundal Collier, and before that 6 years in Arthur Andersen and

NEXT Biometrics to Demonstrate its Latest Fingerprint Sensor Technology for Dual Interface Smart Cards at Trustech 2019

Oslo, November 22, 2019 –NEXT Biometrics (Oslo Bors: NEXT), a global leader in fingerprint sensor technology, announces that it will present its latest product for the smart card industry from November 26 to 28 at stand E044 at Trustech event in Cannes, France. NEXT’s fingerprint sensor technology for dual interface (DI) smart cards is using a Secure Element from Infineon Technologies AG. Both companies had announced a partnership to develop reference platforms in November 2018 aiming at accelerating the adoption of biometric smart cards in a multitude of applications. The biometric

All-round service at heroal

Manuel Vergers, Head of Service, explains in an interview what the Service Department stands for and what sets heroal Service apart from the competitionWhy is the Service Department so important for heroal? These days, it’s normal for most medium-sized companies to have a service department that serves as a point of contact and is available to answer customers’ questions. It’s just the same at heroal: we advise our customers on any questions relating to heroal system solutions. This could be regarding any particular product features that need to be explored during the planning phase, or

Open Letter from Clearance Capital to Hoivatilat plc shareholders recommending that you reject the Tender Offer in its current form as it does not fully reflect the value of the Company.

Dear Fellow Hoivatilat plc Shareholders, The funds we manage hold 8.6% of Hoivatilat plc (“Hoivatilat” or the “Company”). Following careful consideration of Aureit Holding Oy's (“Aedifica” or “the Offeror”) voluntary public cash tender offer for the shares in Hoivatilat announced on 4 November 2019 (“Tender Offer”), we have come to the conclusion that the Tender Offer does not reflect the value of the Company and its unique growth prospects. We have, therefore, decided to reject the offer. We urge you to do the same. In reaching our decision, we have reflected on Aedifica’s

Carbiotix announces the launch of its second generation gut heath diagnostic platform

Carbiotix AB (publ) ("Carbiotix") announces today that the company will launch its second generation gut health diagnostics platform in Q1 of 2020. This platform will allow Carbiotix to attain a leading position in the diagnostics area by targeting a global market, which is estimated to be worth 800 million Euro for both consumer and clinical microbiome diagnostic services.Kristofer Cook, CEO for Carbiotix, comments “Carbiotix current diagnostic platform for gut health is based on a Fiber Loving Bacteria (FLB) Index, which is a simplified and cost-effective gut health test based on key

Clinical data for Episealer® to be presented at sports medicine congress in the United Kingdom

Episurf Medical (Nasdaq: EPIS B) today announces that its implant technology, and clinical results from the use of the Episealer® implant, will be presented at the sports medicine congress “Sports Knee 2019”. The congress will be arranged at St George’s Park Burton-on-Trent on November 25-26, 2019. The presentation will be held by Associate Professor Tim Spalding, University Hospitals Coventry and Warwickshire NHS Trust.  The clinical results come from a European multicenter study with 100 patients in the “gap age”, 35-60 years old, that have undergone treatment of focal chondral defects

Promore Pharma AB (publ) Interim report January – September 2019

June – September · Net sales amounted to 1,3 (1,0) MSEK. · The operating loss for the period was 6,7 (-7,4)MSEK · Net loss was 6,7 (-7,6) MSEK corresponding to earnings per share of SEK -0,33 (-0,38) · Cash flow from operating activities amounted to -6,9 (-6,7) MSEK · Cash and cash equivalents amounted to 13,0 (39,5) MSEK January – September · Net sales amounted to 2,5 (1,1) MSEK · The operating loss for the period was 19,6(-26,1) MSEK · Net loss was 19,5 (-25,3) MSEK corresponding to earnings per share of SEK -0,96 (-1,25) · Cash flow from operating

Primary insider disclosure

Fornebu, 22 November 2019 The following primary insiders (or their related parties as described below) have, as part of the company’s incentive program, committed to acquire shares in Ocean Yield ASA (the "Company" or "Ocean Yield"): * Lars Solbakken, CEO, has through his wholly owned company Finmarine AS, committed to acquire 85,000 shares in Ocean Yield. Upon completion of such acquisition, Lars Solbakken will own 1,550,880 shares in the Company (all shares are owned indirectly through the wholly owned company Finmarine AS). * Andreas Røde, Head of Business Development & M&A.,

Akastor ASA: Øyvind Paaske appointed as CFO in Akastor

Øyvind Paaske has been appointed as Chief Financial Officer in Akastor ASA effective from 1 March 2020. He replaces Leif H. Borge who will remain in the position up to this date, after which he will assume a new position in a company outside the Aker group. Øyvind Paaske (35) joined the investment team in Akastor in 2014. Prior to this, he held the position as Investment Manager in Aker ASA. He holds an MSc in Financial Economics from the Norwegian School of Economics and Business Administration (NHH) and UNC Kenan-Flagler Business School. Akastor CEO Karl Erik Kjelstad says: “I am

2cureX publishes interim report for the third quarter of 2019

2cureX AB (“2cureX”) hereby publishes interim report for the third quarter of 2019. The interim report is available as an attached document as well as on the company’s website (www.2curex.com). Below follows a short summary of the report.CEO Ole Thastrup comments “We remain fully focused on the commercialization of IndiTreat with a planned launch of IndiTreat in 2020. Further, we push our multiple clinical studies to capitalize on a significantly increased interest for introducing 3D functional testing in cancer care. Pre-launch activities to support the market launch of IndiTreat® in

Enersize Oyj Interim Report for the third quarter of 2019

Enersize hereby presents the interim report for the period July - September 2019 and can show increasing turnover. Please note that this is not a financial report but primarily a summary of the most significant events during the past quarter. In information with the requirements of the Nasdaq Stockholm First North Growth Markets regulations, Enersize releases financial reports on a half- and full-year basis.The report (in Swedish) can be downloaded from Enersize's web page https://enersize.com/rapporter/.

Changes in Scandic’s organization to strengthen portfolio development

Scandic Hotels is making organizational changes to further strengthen its focus on developing the hotel portfolio. Svein Arild Steen-Mevold, who is currently Head of Scandic Hotels Norway, has been appointed as Chief Portfolio Officer with overall responsibility for Scandic’s portfolio management.Scandic’s hotel portfolio has grown rapidly in recent years and today, the Group is the clear leading hotel company in the Nordic countries. During the year, the company initiated a review of its portfolio in addition to working to make investment operations more effective and evaluating future

OrganoClick receives SEK 3.7 million in funding from strategic innovation program Bioinnovation for development of biobased binders for nonwoven

OrganoClick has been granted funding of SEK 3.7 million for development of its biobased binders for nonwoven used in hygiene and medical applications. The project will be executed in a Swedish-Finnish consortium including 3 players spanning the whole value chain from binder production (OrganoClick), a nonwoven producer and a product owner which manufactures hygiene and medical products for the healthcare sector. The project will be co-financed by the Swedish strategic innovation program BioInnovation – a joint program by Vinnova, Formas and the Swedish Energy Agency together with Business

SRV will implement a wellbeing centre in Kirkkonummi

SRV GROUP PLC     INVESTOR NEWS     22 NOVEMBER 2019      09:30 EET SRV will implement a wellbeing centre in Kirkkonummi SRV further bolsters its position as one of Finland’s largest builders of hospitals and healthcare buildings. The municipality of Kirkkonummi chose SRV to carry out the construction contract for the largest investment in its history, a new wellbeing centre. The investment is estimated to amount to a total of EUR 44.5 million, of which SRV’s share is about EUR 32 million. The project will be recognised in SRV’s order backlog in November. The Kirkkonummi wellbeing

INITIATOR PHARMA: Q3 2019 report

Financial Highlights Initiator Pharma A/S is a Danish registered company, and is reporting its financial situation in Danish kroner (DKK). Initiator Pharma A/S was registered on May 2, 2016.  +--------------------------------------------+|Third Quarter (2019-07-01 – 2019-09-30) |+--------------------------------------------+| || · Net revenues were TDKK 0 (0) || · EBIT was TDKK -1,969 (-3,699) || · Earnings per share was DKK –0.08 (-0.21)|+--------------------------------------------+|

Interim Report January 1 – September 30, 2019

ChromoGenics acquires own sputtering capacity and strengthens the company’s strategy to have stable and quality-assured production of sputtered film for dynamic glassThird quarter of 2019 · Net sales for the period amounted to SEK 14.0 (0.0) million and earnings to SEK -20.0 (-12.5) million, which corresponds to earnings per share of SEK -0.07 (-0.30). Deliveries of backlogged customer orders for dynamic products were delayed during the quarter, which has meant that net sales have been postponed. · Gross profit amounted to SEK -4.9 million, which is a decrease of SEK -0.6 million

Redeye initiates coverage of Medicover

We initiate coverage on Medicover. Medicover has over twenty years of history of providing healthcare and diagnostic services to patients in Central and Eastern Europe (CEE) and has built a leading position in several of these fast-growing private healthcare markets. Despite a strong performance for the share in 2019, we believe the Medicover growth story still is underestimated by the market, and that the stock is currently trading at a discount to its peers. Read more and download the research update: http://bit.ly/339rBTV Start following companies at Redeye to receive the latest

There are no items matching the current filter
There are no more items matching the current filter
Back to top